Mesenchymal stem cells promote tumor angiogenesis via the action of transforming growth factor β1

GC Li, HW Zhang, QC Zhao, LI Sun… - Oncology …, 2016 - spandidos-publications.com
Mesenchymal stem cells (MSCs) may influence the growth and metastasis of various human
malignancies, including hepatocellular carcinoma (HCC). Therefore, the underlying …

Targeting TGF-β in prostate cancer: therapeutic possibilities during tumor progression

E Jones, H Pu, N Kyprianou - Expert opinion on therapeutic targets, 2009 - Taylor & Francis
Background: TGF-β regulates prostate growth by inhibiting epithelial cell proliferation and
inducing apoptosis through eliciting a dynamic signaling pathway. In metastatic prostate …

Behavior of seeds and soil in the mechanism of metastasis: a deeper understanding

L Mathot, J Stenninger - Cancer science, 2012 - Wiley Online Library
The so‐called “seed and soil” hypothesis proposed by S tephen P aget in 1889 to explain
the metastatic behavior of cancer cells and the homing of certain cancers to “selected” sites …

Targeting tumor-related immunosuppression for cancer immunotherapy

G Frumento, T Piazza, E Di Carlo… - Endocrine, Metabolic & …, 2006 - ingentaconnect.com
Tumors produce several factors, such as Prostaglandins (PGs), Interleukin (IL)-10, Vascular
Endothelial Growth Factor (VEGF) and Transforming Growth Factor (TGF)-β, which may …

Systemic blockade of transforming growth factor-β signaling augments the efficacy of immunogene therapy

S Kim, G Buchlis, ZG Fridlender, J Sun, V Kapoor… - Cancer research, 2008 - AACR
Locally produced transforming growth factor-β (TGF-β) promotes tumor-induced
immunosuppression and contributes to resistance to immunotherapy. This article explores …

Inhibition of HIF prolyl hydroxylase-2 blocks tumor growth in mice through the antiproliferative activity of TGFβ

AK Ameln, A Muschter, S Mamlouk, J Kalucka, I Prade… - Cancer research, 2011 - AACR
Virtually all solid tumors are dependent on a vascular network to provide them with the right
amount of nutrients and oxygen. In that sense, low oxygen tension or hypoxia leads to an …

Systemic delivery of oncolytic adenoviruses targeting transforming growth factor-β inhibits established bone metastasis in a prostate cancer mouse model

Z Hu, J Gupta, Z Zhang, H Gerseny, A Berg… - Human gene …, 2012 - liebertpub.com
We have examined whether Ad. sTβRFc and TAd. sTβRFc, two oncolytic viruses expressing
soluble transforming growth factor-β receptor II fused with human Fc (sTGFβRIIFc), can be …

The crosstalk of RAS with the TGF-β family during carcinoma progression and its implications for targeted cancer therapy

M Grusch, M Petz, T Metzner, D Ozturk… - Current cancer drug …, 2010 - ingentaconnect.com
Both RAS and transforming growth factor (TGF)-β signaling cascades are central in
tumorigenesis and show synergisms depending on tumor stage and tissue context. In this …

Molecular prognostic factors in adenocarcinoma of the esophagus and gastroesophageal junction

SM Lagarde, FJW ten Kate, DJ Richel… - Annals of surgical …, 2007 - Springer
Objective This review describes genetic and molecular changes related to adenocarcinoma
of the esophagus and gastroesophageal junction (GEJ) with emphasis on prognostic value …

Tranilast inhibits the growth and metastasis of mammary carcinoma

R Chakrabarti, V Subramaniam, S Abdalla… - Anti-cancer …, 2009 - journals.lww.com
Abstract Tranilast (N-[3, 4-dimethoxycinnamonyl]-anthranilic acid) is a drug of low toxicity
that is orally administered, and has been used clinically in Japan as an antiallergic and …